Dataset Information

MiR-155 regulates the ability of circulating cancer cells to colonize and establish metastasis

ABSTRACT: Abstract: Metastases are established through a complex multistep process by which tumor cells disseminate from the primary tumor and expand at distant sites. Traditionally, studies on metastasis have focused on proteins and protein-coding genes, but recently microRNAs (miRNAs) have achieved increasing interest. miRNAs involved in the metastatic process are poorly defined, and while the use of clinical tissue samples or in vitro assessment for study of the first phases of the metastatic process is not feasible; such processes may be studies using in vivo models created by inoculation of human cell lines into mice. We have used such a model system consisting of three isogenic human cancer cell lines that are equally tumorigenic in mice, but while two of these cell lines give rise to metastasis at different rates, the last one disseminates single cells that remain dormant in distant organs. Using a global LNA- based miRNA microarray platform, 28 miRNAs were found to be significantly altered between the metastatic and non-metastatic cell lines, with mir-155 being the miRNA exhibiting the largest difference in expression level and central in a network analysis. Examining the potential targets of miR-155 identified calumenin, solute carrier family 26 (sulfate transporter) member 2 (SLC26A2), Integrin αV, and CD73, which showed an inverse expression pattern to miR-155 in the metastatic and non-metastatic cell lines as determined by immunocytochemical staining. The miRNAs identified in this study could be markers of the ability of cancer cells to colonize at distant organs. global microRNA profiling of three breast cancer cell lines with different metastatic potential derived from MDA-435

ORGANISM(S): Homo sapiens

SUBMITTER: Søkilde Rolf

PROVIDER: S-ECPF-GEOD-37719 | biostudies-other |

REPOSITORIES: biostudies-other

ACCESS DATA

Similar Datasets

Project description:Metastasis is the leading cause of mortality from kidney cancer, and understanding the underlying mechanism of this event will provide better strategies for its management. Here we investigated the biological, functional, and clinical significance of lncTCL6 and its interacting miR-155 in clear cell renal cell carcinoma (ccRCC). We employed a comprehensive approach to investigate the lncTCL6-miR-155-Src/Akt-mediated epithelial-to-mesenchymal transition (EMT) pathway as a novel regulatory mechanism in ccRCC progression. Expression analyses revealed that lncTCL6 is downregulated in ccRCC compared with normal tissues. Overexpression of lncTCL6 in ccRCC cell lines impaired their oncogenic functions, such as cell proliferation and migration/invasion, and induced cell-cycle arrest and apoptosis; conversely, depletion of lncTCL6 rescued these phenotypic effects. Furthermore, lncTCL6 directly interacted with miR-155. Unlike lncTCL6, miR-155 was overexpressed in ccRCC. Stable knockdown of miR-155 phenocopied the effects of lncTCL6 overexpression. Conversely, reconstitution of miR-155 and suppression of lncTCL6 in noncancerous renal cell HK2 induced tumorigenic characteristics. Patients with higher expression of lncTCL6 and lower expression of miR-155 had better survival probability. When overexpressed, lncTCL6 recruited STAU1 and mediated decay of Src mRNA, followed by a marked downregulation of an integrated network of Src target genes involved in migration, invasion, and EMT. However, the interaction between miR-155 and lncTCL6 attenuated the regulatory role of lncTCL6 on Src-mediated EMT. In conclusion, this study is the first report documenting the lncTCL6-miR155-Src/Akt/EMT network as a novel regulatory mechanism in aggressive ccRCC and a promising therapeutic target to inhibit renal cancer. SIGNIFICANCE: This study's investigation of noncoding RNA interactions in renal cell carcinoma identify miRNA-155-lncRNA TCL6-mediated regulation of the Src-Akt-EMT network as a novel mechanism of disease progression and metastasis.

Dataset Information

MiR-155 regulates the ability of circulating cancer cells to colonize and establish metastasis

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets